Aktis Oncology, Inc. (AKTS)
$26.69+2.73%Close
BUY
Key stats
Short interest · FINRA settlement 2026-08-14
- Market cap
- $1.4B
- Avg volume
- 321.4K
- Beta
- 0.45
- P/E (TTM)
- -25.42
- Short % float
- 713.49%
- Days to cover
- 15.0
- SI change
- -0.7%
- 1W
- +6.76%
- 1M
- +10.24%
- 3M
- +29.69%
- YTD
- +19.15%
- vs SPY 1W
- +6.96%
- vs SPY 1M
- +6.53%
- vs SPY 3M
- +27.65%
- vs SPY YTD
- +7.04%
Sector peers
Same-sector names ranked by LOPJLB quality proximity · Healthcare
- CTKBBUYCytek Biosciences, Inc.RECOVERYQ -10$4.58+3.15%
- HTFLBUYHeartflow, Inc. Common StockBULLQ 46$49.89-0.62%
- IMCRBUYImmunocore Holdings plcRECOVERYQ 5$37.40+2.16%
- JSPRBUYJasper Therapeutics, Inc.CRISISQ -12$0.72+0.00%
- APVOBUYAptevo Therapeutics Inc.CRISISQ -28$2.46+2.07%
- GANXBUYGain Therapeutics, Inc.RECOVERYQ -12$1.91-4.50%
- ZNTLSELLZentalis Pharmaceuticals, Inc.CRISISQ -5$3.88+3.19%
- SNYRSELLSynergy CHC Corp.CRISISQ 1$0.10+0.00%
- COSMSELLCosmos Health Inc.RECOVERYQ -3$0.21+0.00%
- MENSSELLJyong Biotech Ltd. Ordinary SharesRECOVERYQ -30$2.23+0.45%
- DCOYSELLDecoy Therapeutics Inc.CRISISQ -24$2.98-4.18%
- KPRXBUYKiora Pharmaceuticals, Inc.RECOVERYQ -16$2.59-5.82%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
FUNDAMENTALS
[SCORES & PROFILE]
- FUND
- 11
- VALUE
- 8
- GROWTH
- 19
- GARP
- 8
- TYPE
- Balanced
Composite of Value · Growth · GARP
ROIC-19.4%
REV YoY-
ROE-32.3%
EPS YoY-
ROA-10.3%
GROSS82
OP-813
NET-679
[VALUATION]
P/E TTM-25.42
P/E FWD-
SECTOR PE22.57
INDUSTRY PE17.06
P/B3.05
P/FCF-
EV/EBITDA-22.52
EV/EBIT-
PEG-
FCF YIELD-
RISK
INT COV-
D/E2.32
ALTMAN Z-
CURR RATIO16.33
ND/EBITDA-
BETA0.45
